Organ Preservation Market to Witness 5.3% CAGR During the Forecast Period

Organ Preservation Market Forecast, 2034

The global organ preservation market is being shaped by advances in transplantation, increasing demand for donor organs, and the development of technologies that can maintain organ viability for longer periods. Preservation solutions and perfusion systems help reduce ischemic injury and support the safe transportation, assessment, and preparation of donor organs before transplantation. The transition from conventional cold storage toward machine perfusion is also creating new opportunities to assess organ quality and expand the pool of transplantable organs.

The global organ preservation market size was valued at USD 308.32 million in 2025 and is projected to reach USD 324.66 million in 2026 and USD 490.75 million by 2034, registering a CAGR of 5.3% during 2026–2034.

Market Drivers

Growing Burden of End-Stage Organ Diseases

The prevalence of kidney, liver, heart, and lung disorders is sustaining demand for transplantation and, consequently, for reliable organ preservation solutions. Preservation technologies help maintain donor-organ viability between procurement and implantation, supporting transplant centers in managing increasingly complex procedures.

Advances in Machine Perfusion Technologies

Hypothermic and normothermic machine perfusion systems are providing transplant teams with alternatives to conventional static cold storage. These technologies can maintain organs under controlled conditions while enabling functional assessment, which can support the use of marginal or extended-criteria donor organs.

Expansion of Organ Transplantation Infrastructure

Investments in transplant centers, organ procurement networks, and specialized healthcare infrastructure are strengthening the clinical environment for organ preservation technologies. Better coordination between procurement organizations and transplant hospitals also supports the adoption of advanced preservation and transportation systems.

Increasing Focus on Donor Organ Utilization

Healthcare providers are seeking ways to improve the proportion of recovered organs that can be successfully transplanted. Preservation technologies that extend viability or enable organ assessment can help reduce organ non-utilization and improve the efficiency of transplantation programs.

Market Challenges

Time-Sensitive Organ Transportation

Donor organs must be transported within strict clinical windows to preserve viability and transplantation outcomes. Delays caused by transportation disruptions, scheduling changes, weather conditions, or coordination problems can reduce the effective preservation period and complicate transplant logistics.

Complexity of Advanced Preservation Systems

Machine perfusion systems require specialized equipment, monitoring capabilities, trained personnel, and appropriate clinical protocols. The operational complexity can make implementation more difficult for smaller transplant centers and healthcare facilities with limited technical resources.

Limited Standardization Across Preservation Protocols

Differences in preservation techniques, perfusion parameters, organ assessment criteria, and clinical protocols can complicate technology adoption across transplant centers. Greater standardization is needed to facilitate consistent evaluation of donor organs and broader integration of advanced preservation systems.

Specialized Infrastructure and Skilled Workforce Requirements

Advanced organ preservation depends on specialized surgical, perfusion, laboratory, and transportation capabilities. Shortages of trained personnel and limited access to suitable infrastructure can restrict the deployment of sophisticated preservation technologies in emerging transplant systems.

Market Segmentation

• By Solution: University of Wisconsin (UW), Histidine-Tryptophan-Ketoglutarate (HTK), Collins, Others

• By Organ Type: Kidneys, Heart, Lung, Liver, Others

• By Technique: Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others

• By Region: North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Regional Insights

North America Organ Preservation Market Analysis

The North American organ preservation market is supported by established transplantation infrastructure, advanced healthcare systems, and strong adoption of machine perfusion technologies. The presence of specialized transplant centers and continued investment in medical-device innovation is creating a favorable environment for advanced preservation solutions.

Europe Organ Preservation Market Analysis

The European market is reinforced by well-developed public healthcare systems, established organ donation networks, and continued research into transplantation technologies. Collaboration among transplant centers and healthcare institutions is supporting the adoption of advanced preservation and organ-assessment techniques.

Asia Pacific Organ Preservation Market Analysis

The Asia Pacific market is strengthened by expanding healthcare infrastructure, increasing transplantation activity, and greater investment in organ donation programs. Improvements in specialized transplant facilities and growing access to machine perfusion technologies are creating opportunities for preservation-system providers across the region.

Middle East & Africa Organ Preservation Market Analysis

The Middle East & Africa market benefits from investments in specialized healthcare infrastructure and the development of organ transplantation programs. Greater awareness of organ donation and improvements in transplant capabilities are supporting demand for reliable preservation and transportation solutions.

Latin America Organ Preservation Market Analysis

The Latin American market is underpinned by improvements in transplant services, healthcare infrastructure, and organ donation initiatives. Expansion of specialized transplant centers and greater access to preservation technologies are creating opportunities for suppliers across the regional healthcare system.

Key Players Analysis

The organ preservation market includes specialized medical technology companies, preservation-solution manufacturers, and providers of machine perfusion and organ-transportation technologies. Competition is centered on preservation efficacy, organ viability, system reliability, clinical evidence, ease of use, and the ability to integrate preservation with organ assessment and transportation.

Key players include XVIVO, TransMedics, Inc., 21st Century Medicine, Bridge to Life Ltd., and Preservation Solutions, Inc.